Exercise Tips

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Drugs, Rock and Roll

Drugs, Rock and Roll

Blasting music tied to drinking and drugs: study.  Full Article 

Contraception Controversy

Contraception Controversy

U.S. Catholic groups sue to block contraception mandate.  Full Article 

Emergency Plan

Emergency Plan

Exclusive: Drugmakers weigh emergency supply plan for Greece.  Full Article 

Cancer Screening

Cancer Screening

Lung cancer tests advised for some heavy smokers.  Full Article 

Diabetes Risks

Diabetes Risks

"Pre-diabetes," diabetes rising among U.S. teens.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Antibiotics no help against most sinus infections: study

Related Topics

Stocks

   

Wed Feb 15, 2012 7:11am IST

(Reuters) - Antibiotics don't help fight most sinus infections, although doctors routinely prescribe them for that purpose, according to a U.S. study.

Researchers whose work was published in the Journal of the American Medical Association found that antibiotics didn't ease patients' symptoms or get them back to work any sooner than an inactive placebo pill.

Antibiotics are known to fuel the evolution of drug-resistant bacteria and experts have grown increasingly worried about overuse.

This is a particular concern with sinus infections, because doctors can't tell if the disease is caused by bacteria or by a virus, in which case antibiotics are useless.

"There is not much to be gained from antibiotics," said Jane Garbutt of Washington University School of Medicine in St. Louis, who led the study.

"Rather than give everybody an antibiotic hoping to find the (patients) with bacteria, our findings would suggest refraining from antibiotics and doing what we call watchful waiting," she told Reuters Health.

That involves keeping an eye on patients to see if they get better, but not using drugs other than over-the-counter painkillers.

People with sinus infections, also called acute sinusitis, have lasting and severe cold-like symptoms such as a runny nose and pain around the eyes, nose or forehead.

"It's the fifth most common reason antibiotics are prescribed for adults. It's hard for doctors not to give an antibiotic because patients are so miserable, and we don't have anything else to give them," said Garbutt.

Garbutt and her colleagues used official U.S. guidelines to identify patients with sinus infections. They randomly assigned 166 adults to either placebo pills or a 10-day treatment with the antibiotic amoxicillin.

Based on patient ratings on a symptom scale known as the modified Sinonasal Outcome Test-16, or SNOT-16, the researchers found little difference between the two patient groups.

Using the scale, where 0 equals "no problem" and 3 a "severe problem," the antibiotic group rated their symptoms at 1.12 after three days, while the placebo group averaged 1.14.

After seven days, there were signs of benefit from the antibiotic, but the effect was small and had vanished another three days later.

After 10 days, 78 percent of the people on antibiotics and 80 percent of the placebo-treated people said they felt a lot better or no longer had symptoms.

Fewer than two percent of sinus infections are bacterial, said Anthony Chow, an expert in infectious diseases at the University of British Columbia in Vancouver, Canada.

"Most cases are viral, and the vast majority don't require antibiotics," he said.

"Antibiotics have been abused, so there is a need to be more cautious in prescribing them and to hold back."

But he said that antibiotics still do have a place and recently chaired a committee at the Infectious Diseases Society, which has developed guidelines to help spot infections that are more likely to be bacterial.

Those guidelines, still in press, recommend treating only patients whose symptoms last for at least 10 days and keep worsening, who are severely sick with high fever and other symptoms, or who improve and then get worse again. SOURCE: bit.ly/A4EKuo

(Reporting from New York by Frederik Joelving at Reuters Health; editing by Elaine Lies and Bob Tourtellotte)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.